Zai Lab receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zai Lab Ltd (9688)
Zai Lab Ltd stock price live, this page displays HK 9688 stock exchange data. View the 9688 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zai Lab Ltd real time stock price chart below.
What Is the Zai Lab Ltd Stock Price Today?
The Zai Lab Ltd stock price today is 14.24.
What Is the Stock Symbol for Zai Lab Ltd?
The stock symbol for Zai Lab Ltd is ""9688.""
What Stock Exchange Does Zai Lab Ltd Trade On?
Zai Lab Ltd is listed and trades on the Hong Kong stock exchange.
Is Zai Lab Ltd a Good Stock to Buy?
Determining whether Zai Lab Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9688 quote. (ISIN: KYG9887T1168) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
What Is the Zai Lab Ltd Stock Price Today?
The Zai Lab Ltd stock price today is 14.24.
What Is the Stock Symbol for Zai Lab Ltd?
The stock symbol for Zai Lab Ltd is ""9688.""
What Stock Exchange Does Zai Lab Ltd Trade On?
Zai Lab Ltd is listed and trades on the Hong Kong stock exchange.
Is Zai Lab Ltd a Good Stock to Buy?
Determining whether Zai Lab Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 9688 quote. (ISIN: KYG9887T1168) - Test -{{UPSIDE_OR_DOWNSIDE}} - {{DIVIDEND_YIELD}} - {{CURRENT_YEAR}}
14.24
+0.55(+4.02%)
Closed·
Fair Value
An estimate of a Zai Lab's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.54
14.28
52 wk Range
12.31
35.50
9688 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Zai Lab's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.5414.28
52 wk Range
12.3135.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
9688 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Zai Lab's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
24.10
Upside
+69.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Zai Lab stock hits 52-week low at 16.78 USD
- Investing.com
- Zai Lab receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zai Lab receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Zai Lab Ltd Company Profile
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. Zai Lab Limited has license and collaboration agreements with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure Ltd. to develop and commercialize Tumor Treating Fields; Deciphera Pharmaceuticals, LLC to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx BV to develop and commercialize efgartigimod; Turning Point Therapeutics, Inc. to develop and commercialize products containing repotrectinib; Entasis Therapeutics Holdings Inc. to develop and commercialize Durlobactam with Sulbactam; and Karuna Therapeutics, Inc. to develop and commercialize Xanomeline and trospium chloride, as well as strategic collaboration with Pfizer Inc. for Tisotumab Vedotin. The company was incorporated in 2013 and is based in Pudong, China.
Compare 9688 to Peers and Sector
Metrics to compare | 9688 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship9688PeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.3x | −2.8x | −0.5x | |
PEG Ratio | −0.31 | −0.01 | 0.00 | |
Price/Book | 2.8x | 3.7x | 2.6x | |
Price / LTM Sales | 4.3x | 22.6x | 3.2x | |
Upside (Analyst Target) | 56.1% | 310.0% | 50.1% | |
Fair Value Upside | Unlock | 1.3% | 8.6% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 24.10
(+69.27% Upside)
Earnings
Latest Release
Feb 26, 2026
EPS / Forecast
-0.3599 / -0.2505
Revenue / Forecast
998.23M / 992.59M
People Also Watch
FAQ
What Is the Zai Lab (9688) Stock Price Today?
The Zai Lab stock price today is 14.24 HKD.
What Stock Exchange Does Zai Lab Trade On?
Zai Lab is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Zai Lab?
The stock symbol for Zai Lab is "9688."
What Is the Zai Lab Market Cap?
As of today, Zai Lab market cap is 15.52B HKD.
What Is Zai Lab's Earnings Per Share (TTM)?
The Zai Lab EPS (TTM) is -1.60.
When Is the Next Zai Lab Earnings Date?
Zai Lab will release its next earnings report on May 12, 2026.
From a Technical Analysis Perspective, Is 9688 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Zai Lab Stock Split?
Zai Lab has split 1 times.
How Many Employees Does Zai Lab Have?
Zai Lab has 1869 employees.
What is the current trading status of Zai Lab (9688)?
As of Mar 04, 2026, Zai Lab (9688) is trading at a price of 14.24 HKD, with a previous close of 13.69 HKD. The stock has fluctuated within a day range of 13.54 HKD to 14.28 HKD, while its 52-week range spans from 12.31 HKD to 35.50 HKD.
What Is Zai Lab (9688) Price Target According to Analysts?
The average 12-month price target for Zai Lab is 24.10 HKD, with a high estimate of 43 HKD and a low estimate of 16.875 HKD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +69.27% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.